Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Inventory
Prestige Consumer Healthcare Inc
Inventory Peer Comparison
Competitive Inventory Analysis
Latest Figures & CAGR of Competitors
Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Inventory
$148.6m
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Johnson & Johnson
NYSE:JNJ
|
Inventory
$11.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Inventory
$3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
18%
|
CAGR 10-Years
6%
|
|
Pfizer Inc
NYSE:PFE
|
Inventory
$10.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Merck & Co Inc
NYSE:MRK
|
Inventory
$6.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
0%
|
|
Eli Lilly and Co
NYSE:LLY
|
Inventory
$6.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
See Also
What is Prestige Consumer Healthcare Inc's Inventory?
Inventory
148.6m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Inventory amounts to 148.6m USD.
What is Prestige Consumer Healthcare Inc's Inventory growth rate?
Inventory CAGR 10Y
9%
Over the last year, the Inventory growth was -6%. The average annual Inventory growth rates for Prestige Consumer Healthcare Inc have been 8% over the past three years , 4% over the past five years , and 9% over the past ten years .